全文获取类型
收费全文 | 10289篇 |
免费 | 821篇 |
国内免费 | 607篇 |
专业分类
耳鼻咽喉 | 23篇 |
儿科学 | 165篇 |
妇产科学 | 55篇 |
基础医学 | 480篇 |
口腔科学 | 18篇 |
临床医学 | 1327篇 |
内科学 | 1673篇 |
皮肤病学 | 20篇 |
神经病学 | 2239篇 |
特种医学 | 375篇 |
外科学 | 534篇 |
综合类 | 2391篇 |
现状与发展 | 2篇 |
预防医学 | 320篇 |
眼科学 | 332篇 |
药学 | 937篇 |
13篇 | |
中国医学 | 802篇 |
肿瘤学 | 11篇 |
出版年
2024年 | 28篇 |
2023年 | 213篇 |
2022年 | 331篇 |
2021年 | 569篇 |
2020年 | 466篇 |
2019年 | 437篇 |
2018年 | 513篇 |
2017年 | 447篇 |
2016年 | 469篇 |
2015年 | 418篇 |
2014年 | 823篇 |
2013年 | 690篇 |
2012年 | 630篇 |
2011年 | 671篇 |
2010年 | 541篇 |
2009年 | 517篇 |
2008年 | 543篇 |
2007年 | 510篇 |
2006年 | 443篇 |
2005年 | 393篇 |
2004年 | 297篇 |
2003年 | 290篇 |
2002年 | 248篇 |
2001年 | 184篇 |
2000年 | 175篇 |
1999年 | 137篇 |
1998年 | 125篇 |
1997年 | 95篇 |
1996年 | 80篇 |
1995年 | 70篇 |
1994年 | 43篇 |
1993年 | 28篇 |
1992年 | 31篇 |
1991年 | 21篇 |
1990年 | 31篇 |
1989年 | 25篇 |
1988年 | 33篇 |
1987年 | 18篇 |
1986年 | 24篇 |
1985年 | 22篇 |
1984年 | 24篇 |
1983年 | 7篇 |
1982年 | 26篇 |
1981年 | 10篇 |
1980年 | 5篇 |
1979年 | 4篇 |
1978年 | 7篇 |
1977年 | 3篇 |
1976年 | 1篇 |
1975年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 18 毫秒
41.
参附注射液对大鼠缺血再灌注小肠细胞Bax、Bcl-2及c-myc蛋白表达的影响 总被引:9,自引:0,他引:9
目的 探讨参附注射液对大鼠缺血再灌注小肠细胞Bax、Bcl 2及c myc蛋白表达的影响及它们与肠细胞凋亡的内在联系。方法 健康SD大鼠 36只随机分为 3组 ,空白对照组 (S组 )、缺血再灌注 +生理盐水组 (IR +NS组 )、缺血再灌注 +参附注射液组 (IR +SF组 ) ,每组 12只。采用钳闭肠系膜前动脉制备小肠缺血再灌注模型。免疫组化检测Bax、Bcl 2及c myc蛋白的表达 ,每组选 2 4个视野分别测量光密度值 (OD值 )。TUNEL法检测凋亡的小肠细胞并计算凋亡指数。结果 IR +NS组BaxOD值明显高于S组 (P <0 .0 1) ,IR +SF组BaxOD值明显低于IR +NS组 (P <0 .0 1) ,且低于S组 (P <0 .0 5 )。IR +NS组Bcl 2OD值高于S组 (P <0 .0 5 ) ,且IR +SF组Bcl 2OD值高于S组 (P <0 .0 1) ,但IR +NS组与IR +SF组比较无显著差异。IR +NS组c mycOD值明显高于S组 (P<0 .0 1) ,且明显高于IR +SF组 (P <0 .0 1)。IR +NS组细胞凋亡指数明显高于S组和IR +SF组 (P <0 .0 1) ,而IR +SF组高于S组 (P <0 .0 5 )。结论 参附注射液增加小肠组织Bcl 2蛋白的表达 ,降低Bax及c myc蛋白的表达 ,抑制小肠细胞凋亡 ,保护缺血再灌注小肠。 相似文献
42.
Gazzaniga P. P. Ferroni P. Mina C. Pulcinelli F. M. Rizzo P. A. 《The Italian Journal of Neurological Sciences》1987,8(6):561-566
148 patients with various forms of cerebrovascular disease (CVD) were studied by means of a multiparametric analysis ofin vitro platelet aggregation, based on the following six parameters: ADP and epinephrine primary and secondary aggregation thresholds
and percent maximum aggregation induced by optimal concentrations of ADP and epinephrine. These patients were assigned to
four study groups, according to clinical diagnosis supported by CT scan, of transient ischemic attack and reversible neurological
deficit (TIA-RIND), or completed stroke, in the presence or absence respectively of antiplatelet medical treatment at the
time of the study. A statistically significant increase of thein vitro platelet aggregation was found in 44.4% of the untreated TIA-RIND patients and in 33.9% of the untreated stroke patients.
However this last group showed a higher percentage of very marked hyperaggregation. Differences between the two treated study
groups and controls were not signicant. No difference was found in collagen-and ristocetin-induced aggregation between the
patient groups and the controls.
Sommario 148 pazienti con varie forme di malattia cerebrovascolare, sono stati studiati con analisi multiparametriche dell'aggregazione piastrinica in vitro sulla base dei seguenti sei parametri: le soglie di aggregazione primaria e secondaria e l'aggregazione massima percentuale indotta da ADP ed Epinefrina. Questi pazienti sono stati suddivisi in 4 gruppi di studio in accordo con la diagnosi clinica confortata dai dati della TAC e cioè: TIA, RIND, o rammollimento in presenza o in assenza rispettivamente di un trattamento antiaggregante nel momento dello studio. è stato trovato un aumento statisticamente significativo dell'aggregazione in vitro delle piastrine nel 44.4% dei casi TIA, RIND non trattati e nel 33,9% dei casi di rammollimento non trattati. Quest'ultimo gruppo, però, ha dimostrato una più alta percentuale di iperaggregazione molto marcata. Le differenze tra i 2 gruppi di studio trattati con antiaggreganti e i controlli non erano significative. Inoltre nessuna differenza è stata riscontrata tra i gruppi e i controlli nell'aggregazione indotta da collageno e ristocetina.相似文献
43.
Hidehito Sakaguchi Tetsuji Kawata Shigeki Taniguchi 《The Japanese Journal of Thoracic and Cardiovascular Surgery》2004,52(2):71-74
The surgical approach to ischemic mitral regurgitation with concomitant inferior left ventricular aneurysm remains uncertain
in terms of the indication for operation and the short-and long-term outcomes. We performed concomitant mitral valve repair,
left ventricular reconstruction, and aortic valve replacement on a 71-year-old male with severe ischemic mitral regurgitation,
inferior left ventricular aneurysm, and degenerative aortic regurgitation. Postoperative status was in New York Heart Association
functional class I without mitral regurgitation 8 months after operation. We discuss, and review the procedures reported in
the literature. 相似文献
44.
45.
大鼠脑缺血再灌注后水孔蛋白-4的免疫组化表达与脑水肿关系的研究 总被引:3,自引:0,他引:3
目的 研究大鼠脑缺血再灌注后脑组织中水孔蛋白 - 4 (AQP- 4 )的表达与脑水肿的关系。方法 采用大鼠大脑中动脉栓塞 (MCAO)模型 ,经免疫组化法测定 AQP- 4表达阳性细胞数 ,干、湿重法测定脑水含量 ,脑水肿以脑水含量评价。结果 脑缺血再灌注后 12 h,脑缺血坏死周边区 AQP- 4表达阳性细胞及脑水含量增加 ,于 4 8~ 12 0 h 达到高峰 ,16 8h后仍处于较高水平 ,两者之间呈正相关 (r=0 .95 8,P<0 .0 1)。结论 脑缺血再灌注后AQP- 4参与脑水肿的发生 ,为脑缺血再灌注损伤的重要因素之一。 相似文献
46.
目的探讨1,6-二磷酸果糖(FDP)治疗新生儿缺氧缺血性脑病(HIE)合并心肌损伤的疗效.方法随机分成治疗组和对照组,均给予常规治疗,治疗组加用FDP 0.25~0.4g/(kg·次),1 次d静滴,10 d为一疗程,治疗前后均进行心肌酶测定.结果治疗组临床症状改善及心肌酶恢复效果均优于对照组,两组差异有显著性(P<0.05).结论 FDP对HIE时的脑损伤及心肌损伤均有良好效果. 相似文献
47.
目的:观察纳洛酮,丽珠赛乐,复方丹参联合治疗中,重度新生儿缺氧缺血性脑病(HIE)的效果。方法:将52例中,重度HIE患儿随机分为治疗组和对照组。在综合治疗基础上观察两组患儿意识,呼吸,肌张力,原始反射,惊厥改善所需时间,并作统计学处理。结果:治疗组意识,呼吸,肌张力,原始反射,惊厥改善所需时间少于对照组,P均<0.01,治疗组治疗5d的有效率63.33%,大于对照组的31.82%,P<0.05。结论:在综合治疗基础上联合应用纳洛酮,丽珠赛乐,复方丹参治疗中,重度HIE可较快改善临床表现,缩短病程,提高治愈率。 相似文献
48.
动脉瘤术后血管痉挛的综合治疗(附284例报告) 总被引:3,自引:0,他引:3
目的总结动脉瘤手术后血管痉挛及延迟性缺血性神经功能障碍(DIND)的防治经验。方法回顾性分析284例接受颅内动脉瘤夹闭术病人的临床资料,对颅多普勒超声(TCD)的结果与DIND的发生情况进行统计分析。结果137例病人手术后发生血管痉挛,79例发生DIND。TCD所示血流速度与DIND的发生有密切的相关关系。经治疗,62例DIND病人(78.5%)症状消失。病死率2.5%。结论血管痉挛是导致DIND的主要因素,个体化的综合治疗能明显提高疗效。 相似文献
49.
短暂性脑缺血发作患者血浆中TXB2和PGF1α含量检测 总被引:3,自引:0,他引:3
本文用放射免疫法测定47例短暂性脑缺血发作(TIA)患者血浆中血栓素B_2(TXB_2)和6酮-前列腺F_(1α)(PGF_(1α))的含量。结果发现TIA患者血浆中TXB_2含量增高,PGF_(1α)降低;头颅CT或MRI示有小灶性梗塞者及TIA发作持续时间长于30min者TXB_2升高和PGF_(1α)降低更显著。治疗3个月后,血浆PGF_(1α)显著增高。TXB_2和PGF_(1α)在体内的失平衡是急性脑血管疾病发病的重要机理之一。 相似文献
50.
Tetsuji Kai Yang Il Kim Hirokazu Kitamura Katsunori Kawano Seigo Kitano 《Journal of Hepato-Biliary-Pancreatic Surgery》1997,4(4):423-430
There is a growing body of evidence that the cytokine, tumor necrosis factor-α (TNF-ga), plays an important role in the development
of hepatic ischemia/reperfusion injury. We found that the immunosuppressants, cyclosporine-A (CsA), azathioprine, and FK506,
have protective effects on such injury. The purpose of the present study was to elucidate mechanisms involved in these beneficial
effects of the immunosuppressant, CsA, on liver injury following cold preservation and transplantation, with special reference
to the suppression of TNF-α release. Rat livers were stored in Euro-Collins solution (EC) at 4°C for 6h and orthotopically
transplanted. The animals allotted to two groups: group A (untreated controls) and group B (CsA pretreatment of recipients).
CsA (10 mg/kg, p.o.) was given for 3 consecutive days preoperatively. CsA pretreatment of the recipients significantly improved
the 2-week survival rate (0/6 for group A, 3/6 for group B;P<0.05) and this was associated with a significant decrease in serum TNF-α levels 2h posttransplantation (group A, 69.8±15.7
pg/ml; group B, 22.8±6.8; mean±SEM;n=12 each;P<0.05) and amelioration of sinusoidal endothelial injury, assessed by electron microscopy. Plasma endotoxin levels following
reperfusion of the grafts were not altered by the CsA therapy. Morphologically, CsA pretreatment of the recipients did not
alter activation of Kupffer cells. CsA pretreatment of the recipient aids in preventing cold preservation/reperfusion injury
of the liver graft, possibly by modulating effects of TNF-α. 相似文献